[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Verrica Pharmaceuticals Inc (VRCA)

Verrica Pharmaceuticals Inc (VRCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Verrica Pharmaceuticals Inc 44 West Gay Street Suite 400 WEST CHESTER PA 19380 USA

www.verrica.com Employees: 76 P: 484-453-3300

Sector:

Medical

Description:

Verrica Pharmaceuticals, Inc. operates as a clinical-stage medical dermatology company. It develops and manufactures pharmaceutical products for the treatment of skin diseases such as molluscum contagiosum and dermatology. Verrica Pharmaceuticals, Inc. is based in PA, United States.

Key Statistics

Overview:

Market Capitalization, $K 96,890
Enterprise Value, $K 66,740
Shares Outstanding, K 17,179
Float, K 7,902
% Float 46.00%
Short Interest, K 379
Short Float 2.21%
Days to Cover 9.35
Short Volume Ratio 0.67
% of Insider Shareholders 54.00%
% of Institutional Shareholders 42.45%

Financials:

Annual Sales, $ 35,580 K
Annual Net Income, $ -17,890 K
Last Quarter Sales, $ 5,020 K
Last Quarter Net Income, $ -9,680 K
EBIT, $ -13,530 K
EBITDA, $ -12,750 K

Growth:

1-Year Return -3.80%
3-Year Return -90.21%
5-Year Return -95.11%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 90.94%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.41 on 05/12/26
Next Earnings Date 08/11/26
Earnings Per Share ttm -0.94
EPS Growth vs. Prev Qtr 19.64%
EPS Growth vs. Prev Year 55.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 07/25/25

VRCA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -1,077.78%
Return-on-Assets % -40.75%
Profit Margin % -50.28%
Debt/Equity 0.00
Price/Sales 2.72
Price/Cash Flow N/A
Price/Book 6.02
Book Value/Share 0.93
Interest Coverage -1.31
60-Month Beta 1.49
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.